Vitaspring Biomedical VSBC
OTC VSBC
$0.03 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) Capital Expenditures (2017 - 2019)

Updated

Vitaspring Biomedical's Capital Expenditures came in at $72,997 for FY2022 (year ended Jan 31, 2022).

Analysis

Vitaspring Biomedical (VSBC) Capital Expenditures (2017 - 2019) Analysis & Trends

  • The FY2022 figure represents the lowest annual Capital Expenditures since FY2018.
  • Per Business Quant, earlier fiscal years put Capital Expenditures at -$2,249 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,156.48 Bn 1,125.07 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 623.52 Bn 542.04 Bn 17.26 Bn 1.32 Bn
3 AbbVie 511.52 Bn 484.64 Bn 12.70 Bn 322.00 Mn
4 Merck 366.08 Bn 320.46 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 297.10 Bn 261.09 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 260.97 Bn 234.66 Bn 12.86 Bn 1.86 Bn
7 Amgen 234.36 Bn 189.76 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 193.20 Bn 167.40 Bn 6.22 Bn 140.00 Mn
9 Pfizer 171.61 Bn 118.26 Bn 10.94 Bn 533.00 Mn
10 Vitaspring Biomedical 6.21 Mn 6.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2019 2,249.00
Oct 31, 2018 -2,249.00
Apr 30, 2017 -2,249.00
API Access

Vitaspring Biomedical Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VSBC&period=max&api_key=YOUR_API_KEY